Earnings Bounce Poses Quality Test for Equity Investors

19 7月 2021
6 Minute Read

As the world convalesced from the pandemic, stocks advanced in the second quarter and earnings rebounded across sectors. With business gains broadening amid complex market risks, we think investors should lean on quality to find stocks that will perform well in a normalizing world economy.

Global stocks continued to rise in the second quarter. The MSCI World Index advanced 7.6% in the three-month period through June in local currency terms and was up 14.2% since the beginning of the year. US and Australian stocks led the gains, while emerging markets and Japan underperformed (Display, left). Technology was the top performing sector again after a relatively weak first quarter. (Display, right). Real estate stocks staged a robust rebound from last year’s underperformance, helped by growing evidence that the sector’s worst-case outcomes are less likely post-pandemic.

US and Australia Outperformed; Technology Led Sector Returns Again
Two bar charts show regional stock market returns and MSCI World sector returns for the second quarter 2021.

Past performance and current analysis do not guarantee future results.
*US large-caps represented by S&P 500, Australia by S&P/ASX 300, China by MSCI China A Index, Europe ex UK by MSCI Europe ex UK Index, UK by FTSE All-Share Index, US small-caps by Russell 2000 Index, emerging markets by MSCI Emerging Markets Index, and Japan by TOPIX.
†Based on GICS sectors.
As of June 30, 2021
Source: Bloomberg, FactSet, FTSE, FTSE Russell, MSCI, Nasdaq, S&P, Tokyo Stock Exchange and AllianceBernstein (AB)

The global economy is progressing through the reopening phases in fits and starts. Some countries have seen rapid progress in containing COVID-19 through successful vaccination programs, while others faced setbacks as new variants emerge. Similarly, in equity markets, style leadership was volatile. Value stocks have been the best performing strategy this year but lagged in the second quarter (Display). In fact, quality stocks—typically the most consistent performers through cyclical changes—performed well in the second quarter and through the rotation from growth’s dominance in 2020 to value’s reawakening.

Value Stocks Outperformed Year-to-Date, But Style Returns Shifted in 2Q
MSCI World Style Index returns are shown for the year-to-date through June 2021 and for the second quarter.

Past performance does not guarantee future results.
As of June 30, 2021
Source: FactSet, MSCI and AllianceBernstein (AB)

Market gains were fueled by a return-to-business boom as economies reopened and consumers unleashed pent-up spending. This was reflected in earnings—where, globally, the percentage of companies that have seen upward earnings revisions has risen across every sector (Display). According to our research, many companies that suffered negative revisions in the first quarter enjoyed positive revisions in the second, indicating a healthy broadening of profit growth.

Earnings Revisions Increased Across Sectors
Percentage of companies with upward earnings revisions are shown by MSCI World sector in the first and second quarters of 2021.

Past performance does not guarantee future results.
Based on consensus earnings estimates.
As of June 30, 2021
Source: FactSet, MSCI and AllianceBernstein (AB)

The earnings landscape is reshaping the equity investing environment. During 2020, earnings estimates of MSCI World companies for 2021 dropped by 15%, while the index advanced by 14% in US dollar terms. As a result, the benchmark’s price/earnings ratio surged by 35%. This year, earnings estimates for 2021 rose 13%, while the market increased by 12%—leaving the P/E unchanged.

What’s Driving Share Prices? Earnings Are Back in Focus
Analysis shown of change in MSCI World earnings estimates, index change and price/earnings valuation change in 2020 and 2021.

Past performance does not guarantee future results.
In both charts, earnings per share (EPS) estimates and P/E are based on the change in earnings estimates for the calendar year 2021 during the calendar year shown above. The change in EPS estimates and the MSCI World Index are shown in USD terms.
As of June 30, 2021
Source: FactSet, MSCI and AllianceBernstein (AB)

What do these trends mean? First, last year’s share price gains were predominantly driven by multiple expansion—not by earnings growth, largely on the back of lower interest rates. Second, during the collapse, investors focused on companies whose long-term success wasn’t affected by the short-term economic disruptions, favoring many superstar growths companies whose earnings are far out in the future. Today, share-price gains are more closely linked to current and near-term earnings trends, which is in line with more normal market behavior.

This return to normal poses a test for investors. After this year’s rebound from a dramatic pandemic-induced collapse, earnings growth is forecast to fall back to more normal levels in 2022 (Display). As a result, investors will need to sift for companies with sustainable business drivers and competitive advantages to support healthy long-term cash flows when the initial recovery boost subsides.

Back to Normal: Earnings Growth Poised to Moderate After 2021 Rebound
Forecast earnings growth shown for global and regional indices, for 2021 vs 2020 and 2022 vs 2021.

Past performance does not guarantee future results.
Global represented by MSCI World, US represented by MSCI USA, Europe represented by MSCI Europe ex UK, Japan represented by MSCI Japan and emerging markets represented by MSCI Emerging Markets.
As of June 30, 2021
Source: FactSet, MSCI and AllianceBernstein (AB)

But the path from recovery toward normalcy raises questions. Navigating the economic cycle is tricky, as the unique nature of the coronavirus crisis may have unanticipated and lasting impacts on companies and industries. In addition, the threat of inflation and monetary policy changes is palpable. Meanwhile, in many sectors and industries, valuations remain elevated.

Is This Cycle Different?

Macroeconomic cycles usually provide investors with important clues for market trends. For example, in the US, our research shows that the purchasing manager’s index—a key leading indicator for the stages of an economic cycle—is often a good way to identify effective equity return factors. Over three decades, cyclical value stocks have typically done best during recoveries from recession, while growth stocks excelled when economic growth moderated and defensive stocks led in the expansion and contraction stages. Quality stocks are rarely the stars of the stock market show but tend to be relatively resilient through all four stages.

COVID-19 may have upended some of these trends, at least for now. Indeed, in contrast to the historical evidence, growth stocks thrived during the pandemic in a major global GDP contraction while defensive stocks underperformed. The PMI itself may be distorted by massive central bank actions undertaken to help keep the global economy afloat.

 Growing concerns about inflation add another risk to the outlook. Signs of inflation continued to accumulate in the second quarter, with the US Core Consumer Price Index registering a 0.7% month-on-month leap in May, marking a 3.8% year-over-year increase—its highest annual rate in 25 years. Research by AB economists suggests that this jump is temporary, and historical evidence indicates that, as long as inflation doesn’t rise above 4% for a prolonged period of time, equity returns should not be threatened.

In mid-June, stocks briefly fell and shorter-term bond yields rose when the US Federal Reserve signaled a possible change in its policies. US Fed Chairman Jerome Powell said that the Fed was considering tapering purchases of Treasuries and mortgage securities, and several Fed board members brought forward their forecasts for when policy interest rates would rise. These moves prompted an outperformance of growth stocks in June, probably because they reduced fears that inflation could get out of control, leaving longer-term interest rates lower than at the start of the quarter.

 Macroeconomic uncertainty adds risks to equity markets, while elevated valuations are a lingering concern. At the end of June, the MSCI world Index traded at a price/earnings ratio of 19.8x (Display, left), toward the upper end of its historical range since 1996. However, regional valuations remain diverse. Stocks in the Europe, Asia and emerging markets trade at deep discounts to the global index, and, in most cases, well below their average historical discount (Display, right). It may be a good time for investors who have been underweight non-US stocks to diversify global allocations, in our view.

Differences in Regional Valuations Are Provocative
Left chart shows MSCI World price/earnings ratio over time. Right chart shows regional P/E discounts or premium to MSCI World.

Past performance and current analysis do not guarantee future results.
Based on forecast earnings for the next 12 months. UK represented by MSCI UK, emerging markets by MSCI Emerging Markets, Asia ex Japan by MSCI Asia ex Japan, Japan by MSCI Japan, Europe ex UK by MSCI Europe ex UK and US by MSCI USA
As of June 30, 2021
Source: FactSet, FTSE, MSCI and AllianceBernstein (AB)

Quality Matters in the Next Phase of Recovery

No matter where you invest, we believe focusing on quality is essential today. In different regions and across value, growth and lower-volatility stocks—companies that score high on quality—have a better chance of delivering more consistent results over time, in our view.

But identifying quality can be tricky, and its definition may need to be adjusted for investment style or context. For example, among value stocks, we believe that lower leverage, capital discipline and higher profitability—measured by return on equity—are good quality indicators; our research shows that value stocks with the highest free-cash-flow yields and the highest return on equity (ROE) have delivered strong returns in recoveries from previous recessions. Profitability indicators such as return on assets and return on invested capital are good guides for growth companies. But beyond any specific metric, quality is really defined by the caliber of a company’s competitive advantages, innovative capabilities and management skill. Good companies win over time.

 Finding companies with these traits is always important, but especially so given the uncertainties that prevail about the outlook today—and the potential for a correction after a prolonged bull run in the markets. Investors should check that their portfolio managers are applying a coherent definition of quality—backed by fundamental research—in their stock-selection process.

Instead of trying to time the rotation between growth and value stocks, we believe that diversifying exposures to different types of equities can be effective when complemented with a quality tilt. By focusing on quality stocks—regardless of style or sector—investors can identify the most resilient return potential as the world faces unusual economic, policy and business hurdles along the path back to normal.

The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams and are subject to revision over time.

MSCI makes no express or implied warranties or representations, and shall have no liability whatsoever with respect to any MSCI data contained herein.
The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed or produced by MSCI.

Investment involves risk. The information contained here reflects the views of AllianceBernstein L.P. or its affiliates and sources it believes are reliable as of the date of this publication. AllianceBernstein L.P. makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this publication. This article is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor's personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer of solicitation for the purchase or sale of, any financial instrument, product or service sponsored by AllianceBernstein or its affiliates. This presentation is issued by AllianceBernstein Hong Kong Limited (聯博香港有限公司) and has not been reviewed by the Securities and Futures Commission


About the Author